Furthermore, in N0 breast cancer, especially grade II tumours, uPA and PAI-1 are predictive markers for the response to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy (LoE I-A) [13]. The gene discussed is SERPINE1; the disease is neoplasm.